ACIU
AC Immune Ltd
NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY
$2.97
-1.33% today
Updated 2026-05-06
Market cap
$303.29M
P/E ratio
—
P/S ratio
84.88x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $4
Volume
0.3M
AC Immune Ltd (ACIU) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.64M | $30.27M | $39.09M | $23.21M | $20.25M | $7.19M | $110.46M | $15.43M | $944000.00 | $3.94M | $14.80M | $27.31M | $3.57M |
| Revenue growth (YoY) | — | +250.5% | +29.1% | -40.6% | -12.7% | -64.5% | +1435.4% | -86.0% | -93.9% | +316.8% | +276.1% | +84.5% | -86.9% |
| Cost of revenue | $17.18M | $16.12M | $17.05M | $25.77M | $32.66M | $44.28M | $50.43M | $59.49M | $62.28M | $60.34M | $54.61M | $62.57M | — |
| Gross profit | $-8.54M | $14.15M | $22.04M | $-2.56M | $-12.41M | $-37.08M | $60.02M | $-44.06M | $-62.28M | $3.94M | $-39.80M | $-35.26M | $3.57M |
| Gross margin | -98.9% | 46.8% | 56.4% | -11.0% | -61.3% | -515.5% | 54.3% | -285.5% | -6597.7% | 100.0% | -268.9% | -129.1% | 100.0% |
| R&D | $17.18M | $16.12M | $17.05M | $25.77M | $32.66M | $44.28M | $50.43M | $59.49M | $62.28M | $60.34M | $54.61M | $62.57M | $56.44M |
| SG&A | $2.96M | $2.00M | $2.04M | $4.73M | $6.27M | $7.56M | $16.06M | $18.56M | $10.88M | $9.58M | $10.58M | $11.43M | $11.65M |
| Operating income | $-11.50M | $10.72M | $18.62M | $-10.46M | $-22.54M | $-49.55M | $44.54M | $-61.26M | $-79.01M | $-70.85M | $-53.62M | $-52.38M | $-68.86M |
| Operating margin | -133.1% | 35.4% | 47.6% | -45.0% | -111.3% | -688.8% | 40.3% | -397.0% | -8369.7% | -1800.4% | -362.3% | -191.8% | -1927.3% |
| EBITDA | $-11.21M | $11.02M | $18.91M | $-6.81M | $-22.54M | $-49.66M | $45.81M | $-59.73M | $-70.01M | $-68.03M | $-51.83M | $-48.62M | $-67.75M |
| EBITDA margin | -129.7% | 36.4% | 48.4% | -29.3% | -111.3% | -690.2% | 41.5% | -387.0% | -7415.9% | -1728.7% | -350.2% | -178.0% | -1896.2% |
| EBIT | $-11.50M | $10.72M | $18.62M | $-7.09M | $-23.12M | $-50.62M | $44.54M | $-61.26M | $-72.41M | $-70.39M | $-54.05M | $-50.78M | $-70.26M |
| Interest expense | $0.00 | $4000.00 | $26000.00 | $256000.00 | $147000.00 | $334000.00 | $1.93M | $184000.00 | $581000.00 | $355000.00 | $176000.00 | $133000.00 | $191000.00 |
| Income tax | $0.00 | $31000.00 | $1.64M | $3.62M | $147000.00 | $-1.10M | $1.89M | $184000.00 | $3000.00 | $13000.00 | $10000.00 | $3000.00 | — |
| Effective tax rate | 0.0% | 0.3% | 7.5% | -103.9% | -0.6% | 2.1% | 4.0% | -0.3% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% |
| Net income | $-11.24M | $10.74M | $20.27M | $-7.10M | $-26.41M | $-50.95M | $45.44M | $-61.92M | $-73.00M | $-70.75M | $-54.23M | $-50.92M | $-70.45M |
| Net income growth (YoY) | — | +195.6% | +88.7% | -135.0% | -272.2% | -92.9% | +189.2% | -236.3% | -17.9% | +3.1% | +23.3% | +6.1% | -38.4% |
| Profit margin | -130.2% | 35.5% | 51.9% | -30.6% | -130.4% | -708.2% | 41.1% | -401.3% | -7732.6% | -1798.0% | -366.4% | -186.4% | -1971.6% |